Document is current
Any future updates will be listed below
-
Authors
Sauerbier, Anna
Herberg, Johanna
Stopic, Vasilija
Loehrer, Philipp A. https://orcid.org/0000-0002-5279-2156
Ashkan, Keyoumars
Rizos, Alexandra
Jost, Stefanie T.
Petry-Schmelzer, Jan Niklas https://orcid.org/0000-0003-0749-3840
Gronostay, Alexandra
Schneider, Christian
Visser-Vandewalle, Veerle https://orcid.org/0000-0002-5274-7929
Evans, Julian
Nimsky, Christopher https://orcid.org/0000-0002-8216-9410
Fink, Gereon R. https://orcid.org/0000-0002-8230-1856
Antonini, Angelo https://orcid.org/0000-0003-1040-2807
Martinez-Martin, Pablo
Silverdale, Monty
Weintraub, Daniel https://orcid.org/0000-0003-0633-7168
Schrag, Anette https://orcid.org/0000-0002-9872-6680
Ray Chaudhuri, K. https://orcid.org/0000-0003-2815-0505
Timmermann, Lars
Dafsari, Haidar S. https://orcid.org/0000-0001-8849-4233
,
Adler, Charles
Bhidayasiri, Roongroj
Borghammer, Per
Barone, Paolo
Brooks, David J.
Brown, Richard
Cantillon, Marc
Carroll, Camille
Coelho, Miguel
Falup-Pecurariu, Cristian
Henriksen, Tove
Hu, Michele
Jenner, Peter
Jeon, Beomseok
Kramberger, Milica
Kumar, Padma
Kurtis, Mónica
Leta, Valentina
Lewis, Simon
Litvan, Irene
Lyons, Kelly
Martino, Davide
Masellis, Mario
Mochizuki, Hideki
Morley, James F.
Nirenberg, Melissa
Odin, Per
Pagonabarraga, Javier
Panicker, Jalesh
Pavese, Nicola
Pekkonen, Eero
Postuma, Ron
Rodriguez Violante, Mayela
Rosales, Raymond
Schapira, Anthony
Simuni, Tanya
Stocchi, Fabrizio
Storch, Alexander
Subramanian, Indu
Tagliati, Michele
Tinazzi, Michele
Toledo, Jon
Tsuboi, Yoshio
Walker, Richard
- License Information
-
More Information
Article History
Received: 21 September 2023
Accepted: 2 April 2024
First Online: 8 June 2024
Competing interests
: Anna Sauerbier is funded by the Gusyk program and the Advanced Cologne Clinician Scientist program of the Medical Faculty of the University of Cologne and has received funding from the Prof. Klaus Thiemann Foundation. Johanna Herberg reports no financial disclosures. Vasilija Stopic is funded as part of the Advanced Cologne Clinician Scientist program. Philipp A. Loehrer was funded by the SUCCESS-Program of the University Hospital Marburg and the Parkinson’s Foundation. He reports travel grants from AbbVie. Keyoumars Ashkan has received honoraria for educational meetings, travel and consultancy from Medtronic, St Jude Medical and Boston Scientific. Alexandra Rizos has received honorarium from UCB and was supported by a grant from Medtronic. Stefanie T. Jost has received funding from the Prof. Klaus Thiemann Foundation. Jan Niklas Petry-Schmelzer has been funded by the Cologne Clinician Scientist Program (CCSP)/ Faculty of Medicine/ University of Cologne. Funded by the German Research Foundation (DFG, FI 773/15-1) and received travel grants from Boston Scientific. Alexandra Gronostay reports no financial disclosures. Veerle Visser-Vandewalle is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project-ID 431549029 – SFB 1451, is a member of the advisory boards and reports consultancies for Medtronic, Boston Scientific, Abbott, Insightec and LivaNova. Julian Evans reports no financial disclosures. Christopher Nimsky is consultant for Brainlab and received speaker’s honoraria. Gereon R. Fink is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project-ID 431549029 – SFB 1451. GRF serves as an editorial board member of Cortex, Neurological Research and Practice, NeuroImage: Clinical, Zeitschrift für Neuropsychologie, and DGNeurologie; receives royalties from the publication of the books Funktionelle MRT in Psychiatrie und Neurologie, Neurologische Differentialdiagnose, and SOP Neurologie; receives royalties from the publication of the neuropsychological tests KAS and Köpps; received honoraria for speaking engagements from Bayer, Desitin, DGN, Ergo DKV, Forum für medizinische Fortbildung FomF GmbH, GSK, Medica Academy Messe Düsseldorf, Medicbrain Healthcare, Novartis, Pfizer, and Sportärztebund NRW. Angelo Antonini reports personal consultancy fees from Zambon, AbbVie, Boehringer Ingelheim, GE, Neuroderm, Biogen, Bial, EVER Neuro Pharma, Therevance, Vectura grants from Chiesi Pharmaceuticals, Lundbeck, Horizon 2020 - PD_Pal Grant 825785, Ministry of Education University and Research (MIUR) Grant ARS01_01081, owns Patent WO2015110261-A1, owns shares from PD Neurotechnology Limited. Pablo Martinez-Martin has received honoraria from Editorial Viguera and Movement Disorder Society for lecturing in courses; from AbbVie for speaking in experts’ meetings and from AbbVie and Zambon for participating in the Advisory Board of epidemiological studies. License fee payments for the King’s Parkinson’s Disease Pain Scale, and grants from the International Parkinson and Movement Disorder Society for development and validation of the MDS-Non-Motor Symptoms Scale. Monty Silverdale has received honoraria from Bial, Britannia and Medtronic. Daniel Weintraub reports no financial disclosures. Anette Schrag reports no financial disclosures. K. Ray Chaudhuri has received funding from Parkinson’s UK, NIHR, UCB, and the European Union; he received honoraria from UCB, Abbott, Britannia, US Worldmeds, and Otsuka Pharmaceuticals; and acted as a consultant for AbbVie, UCB, and Britannia. Lars Timmermann reports grants, personal fees and non-financial support from SAPIENS Steering Brain Stimulation, Medtronic, Boston Scientific and St. Jude Medical. Haidar S. Dafsari reports funding of his work by the EU Joint Programme—Neurodegenerative Disease Research (JPND), the Prof. Klaus Thiemann Foundation, the Felgenhauer Foundation, and the Koeln Fortune Program, and honoraria by Boston Scientific, Medtronic, Bial, and Stadapharm.
